Disitamab vedotin binds HER2 on the cell surface, is internalized, and releases MMAE; MMAE then binds beta‑tubulin to inhibit microtubule polymerization, causing G2/M arrest and apoptosis. Tubulin expression alone does not confer targeting—killing occurs only in cells that take up the ADC via HER2.